This was the stock's second consecutive day of losses.

Bio-Techne Corp. closed 7.97% below its 52-week high of $85.57, which the company reached on May 15th.

In a report released on January 10, Conor McNamara from RBC Capital maintained a Hold rating on Bio-Techne (TECH – Research Report), with a ...

These products are not directly competing with other spatial platform technologies. Bio-Techne is well-known for its RNAscope ...

MINNEAPOLIS, Jan. 10, 2025 /PRNewswire/ -- Bio-Techne (NASDAQ: TECH), a global leader in life science tools and reagents, today announced the launch of new designer proteins engineered using ...

This fun logo quiz features five challenging rounds, and includes themed rounds on car logos, food companies and fashion brands. If there’s one thing lockdown taught us, it was that quizzes were a ...

(RTTNews) - Bio-Techne Corp. (TECH), a life sciences company, announced Tuesday that it has won a second claim of reverse engineering by Miltenyi Biotec B.V. & Co. KG, which may appeal the Court's ...

Bio-Techne (TECH) prevailed on another claim that Miltenyi Biotec KG commercialized antibodies developed based on information obtained by ...

Bio-Techne (TECH) prevailed on another claim that Miltenyi Biotec KG commercialized antibodies developed based on information obtained by reverse engineering Bio-Techne’s proprietary R&D Systems ...

MINNEAPOLIS, Jan. 7, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that it prevailed on another claim that Miltenyi Biotec B.V. & Co. KG commercialized antibodies ...

Minnesota-based medical equipment manufacturer Bio-Techne plans to double the size of its laboratory and manufacturing center at 5 Technology Drive with a 54,000-square-foot addition. The Planning ...